X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Pfizer CEO Albert Bourla struck back at proponents of waiving intellectual property protections for COVID-19 vaccine technology this week, which now includes the Biden administration. [Read More]
Thumbnail
Pfizer is testing booster shots and new vaccines that target COVID-19 variants. [Read More]
Pfizer says it is testing a booster and a new variant-targeting vaccine. [Read More]
Pfizer CEO speaks about COVID-19 vaccine booster... [Read More]
CNBC's Meg Tirrell reports on her conversation with Pfizer CEO Albert Bourla regarding the company's outlook amid President Biden's vaccination goals. [Read More]
CNBC's Kelly Evans and Meg Tirrell talk about what's next for the Pfizer and BioNTech Covid vaccine with Pfizer CEO Albert Bourla. [Read More]
Pfizer's (PFE) COVID-19 vaccine is nothing short of a blockbuster drug for the company, bringing in $3.5 billion in revenue in the first three months... [Read More]
Pfizer CEO Albert Bourla said in a LinkedIn post Monday that his company would be donating $70 million worth of medicines to India and was... [Read More]
Thumbnail
Pfizer is moving beyond coronavirus prevention... [Read More]
The CEO of Pfizer said it's "likely" that Americans will need a third shot 12 months after getting fully vaccinated. [Read More]
Loading...
Save As
Preview
Preview